Mokari Atabak (CIK 1678419) reported 45 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Buy CORT (138 shares), Buy CORT (138 shares), Sell CORT (102 shares), Sell CORT (7,089 shares), Sell CORT (4,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Buy | 138 | $15,646 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Buy | 138 | $0 |
| 2026-09-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 102 | $11,565 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 7,089 | $829,102 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 4,200 | $443,248 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 8,956 | $957,892 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 400 | $43,384 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 2,202 | $242,282 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 600 | $66,570 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 4,700 | $531,941 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 15,477 | $1.8M |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 14,222 | $1.6M |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Buy | 80,000 | $1.8M |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 8,267 | $974,951 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 4,783 | $567,908 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 8,103 | $971,939 |
| 2026-08-03 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 1,001 | $120,796 |
| 2026-07-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Buy | 15,833 | $304,944 |
| 2026-07-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Buy | 24,167 | $557,291 |
| 2026-07-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 7,919 | $687,179 |
| 2026-07-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 28,460 | $2.5M |
| 2026-07-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 3,520 | $310,822 |
| 2026-07-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 101 | $9,032 |
| 2026-06-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Buy | 40,000 | $770,400 |
| 2026-06-17 | CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | Sell | 9,434 | $754,909 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03